Table Of Contents

1. Introduction

1.1 Market Definition & Scope

1.2 Research Assumptions & Abbreviations

1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute Opportunity Assessment & Y-o-Y Analysis, 2022-2035

 2.3 Market Size & Forecast, By Segmentation, 2022-2035

  2.3.1 Market Size By Technology

  2.3.2 Market Size By Application

  2.3.3 Market Size By End Use

  2.3.4 Market Size By Component Type

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

     4.1 Adoption & Deployment Metrics

4.1.1 Adoption of POC Molecular Diagnostics Across Hospitals, Clinics, and Home Testing Settings

4.1. Deployment Trends Across Infectious Disease Testing, Oncology/Genetic Screening, and Antimicrobial Resistance Monitoring

4.1.3 Penetration of POC Molecular Diagnostics Across Developed Markets, Emerging Markets, and Rural/Resource-Limited Settings

     4.2 Product & Functional Integration

4.2.1 Preference Patterns for PCR-based Tests, Isothermal Amplification-based Tests, and Sequencing-based POC Platforms

4.2.2 Functional Usage Patterns Across Rapid Infectious Disease Detection, Genetic Disorder Screening, and Pathogen Resistance Analysis

4.2.3 Integration of POC Molecular Diagnostics Within Portable Analyzers, Cartridge-based Kits, and Lab-on-a-chip Platforms

     4.3 Quality & Compliance Trends

4.3.1 Product Quality and Performance Preferences Across Hospitals, Ambulatory Clinics, and Home Testing Applications

4.3.2 Growing Compliance Focus on Regulatory Approvals, ISO Standards, and Laboratory Accreditation Guidelines

4.3.3 Supply Chain Reliability, Component Standardization, and Strategic Partnerships Between Diagnostic Developers and Healthcare Providers

     4.4 Technology & Usage Behavior

4.4.1 Strategic Role of POC Molecular Diagnostics in Enhancing Rapid Clinical Decision-making, Early Disease Detection, and Patient Outcome Optimization

4.4.2 Shift Toward Miniaturized Devices, Automated Sample Processing, and Multiplex Testing Systems

4.4.3 Customer Adoption Drivers Including Test Accuracy, Turnaround Time, Ease of Use, Integration with Healthcare IT, and Cost-Effectiveness

5. Point-of-Care Molecular Diagnostics Market Segmental Analysis & Forecast, By Technology, 2022-2035, Value (USD Billion)

5.1 Introduction

 5.2 PCR-based tests

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022-2035

 5.3 Isothermal amplification-based tests

    5.4 Sequencing-based tests

6. Point-of-Care Molecular Diagnostics Market Segmental Analysis & Forecast, By Application, 2022-2035, Value (USD Billion)

    6.1 Introduction

 6.2 Infectious diseases

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022-2035

 6.3 Oncology

     6.4 Antimicrobial resistance testing

7. Point-of-Care Molecular Diagnostics Market Segmental Analysis & Forecast, By End Use, 2022-2035, Value (USD Billion)

    7.1 Introduction

 7.2 Hospitals

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022-2035

 7.3 Home testing

 7.4 Ambulatory facilities

8. Point-of-Care Molecular Diagnostics Market Segmental Analysis & Forecast, By Component Type, 2022-2035, Value (USD Billion)

    8.1 Introduction

 8.2 Cartridge-based Disposable kits

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022-2035

 8.3 Portable instruments

 8.4 Lab-on-a-chip platforms

9. Point-of-Care Molecular Diagnostics Market Segmental Analysis & Forecast By Region, 2022-2035, Value (USD Billion)

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 Point-of-Care Molecular Diagnostics Market Size & Forecast, By Technology, 2022-2035

 9.2.3 Point-of-Care Molecular Diagnostics Market Size & Forecast, By Application, 2022-2035

 9.2.4 Point-of-Care Molecular Diagnostics Market Size & Forecast, By End Use, 2022-2035

 9.2.5 Point-of-Care Molecular Diagnostics Market Size & Forecast, By Component Type, 2022-2035

 9.2.6 Point-of-Care Molecular Diagnostics Market Size & Forecast, By Country, 2022-2035

  9.2.6.1 USA

  9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Point-of-Care Molecular Diagnostics Market Size & Forecast, By Technology, 2022-2035

 9.3.3 Point-of-Care Molecular Diagnostics Market Size & Forecast, By Application, 2022-2035

 9.3.4 Point-of-Care Molecular Diagnostics Market Size & Forecast, By End Use, 2022-2035

 9.3.5 Point-of-Care Molecular Diagnostics Market Size & Forecast, By Component Type, 2022-2035

 9.3.6 Point-of-Care Molecular Diagnostics Market Size & Forecast, By Country, 2022-2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Point-of-Care Molecular Diagnostics Market Size & Forecast, By Technology, 2022-2035

 9.4.3 Point-of-Care Molecular Diagnostics Market Size & Forecast, By Application, 2022-2035

 9.4.4 Point-of-Care Molecular Diagnostics Market Size & Forecast, By End Use, 2022-2035

 9.4.5 Point-of-Care Molecular Diagnostics Market Size & Forecast, By Component Type, 2022-2035

 9.4.6 Point-of-Care Molecular Diagnostics Market Size & Forecast, By Country, 2022-2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Point-of-Care Molecular Diagnostics Market Size & Forecast, By Technology, 2022-2035

 9.5.3 Point-of-Care Molecular Diagnostics Market Size & Forecast, By Application, 2022-2035

 9.5.4 Point-of-Care Molecular Diagnostics Market Size & Forecast, By End Use, 2022-2035

 9.5.5 Point-of-Care Molecular Diagnostics Market Size & Forecast, By Component Type, 2022-2035

 9.5.6 Point-of-Care Molecular Diagnostics Market Size & Forecast, By Country, 2022-2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Point-of-Care Molecular Diagnostics Market Size & Forecast, By Technology, 2022-2035

 9.6.3 Point-of-Care Molecular Diagnostics Market Size & Forecast, By Application, 2022-2035

 9.6.4 Point-of-Care Molecular Diagnostics Market Size & Forecast, By End Use, 2022-2035

 9.6.5 Point-of-Care Molecular Diagnostics Market Size & Forecast, By Component Type, 2022-2035

 9.6.6 Point-of-Care Molecular Diagnostics Market Size & Forecast, By Country, 2022-2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 Egypt

  9.6.6.5 South Africa

  9.6.6.6 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Key Strategies Adopted (%), By Key Players, 2025

  10.2.2 Year-Wise Strategies & Development, 2022 – 2035

  10.2.3 Number Of Strategies Adopted By Key Players, 2025

 10.3 Market Share Analysis, 2025

 10.4 Product/Service & Application Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Application Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

 10.6.1 Abbott Laboratories

  10.6.1.1 Company Overview & Snapshot

  10.6.1.2 Product/Service Portfolio

  10.6.1.3 Key Company Financials

  10.6.1.4 SWOT Analysis

 10.6.2 Roche Diagnostics

 10.6.3 Danaher Corporation (Cepheid)

 10.6.4 bioMérieux SA

 10.6.5 QIAGEN N.V.

 10.6.6 Thermo Fisher Scientific

 10.6.7 QuidelOrtho Corporation

 10.6.8 Hologic

 10.6.9 Becton Dickinson (BD)

 10.6.10 Bio-Rad Laboratories

 10.6.11 Meridian Bioscience

 10.6.12 Biocartis Group NV

 10.6.13 Co-Diagnostics

 10.6.14 Binx Health

 10.6.15 Molbio Diagnostics Pvt. Ltd.

 10.6.16 GenMark Diagnostics

 10.6.17 Siemens Healthineers

 10.6.18 Orasure Technologies

 10.6.19 Visby Medical

 10.6.20 AccuBioTech Co. Ltd.

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions on Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures